Statin Therapy Results in the Real World Practice in the Czech Republic (STEP)
Statins are the first choice treatment of dyslipidemia, a major contributor to cardiovascular diseases. Statins also have enough evidence to demonstrate decrease of morbidity and mortality from cardiovascular diseases. Even though statin therapy is effective treatment of dyslipidaemia not all patients reach the goal levels.
The aim of the study is to estimate proportion of patients who achieved the therapeutic goal (LDL-C. total cholesterol, HDL-C and triglycerides levels) after at least one year of a statin therapy.
|Study Design:||Time Perspective: Retrospective|
|Official Title:||Statin Therapy Results in the Real World Practice in the Czech Republic|
- LDL-C [ Time Frame: one year ] [ Designated as safety issue: No ]
- Total cholesterol [ Time Frame: one year ] [ Designated as safety issue: No ]
- HDL-C [ Time Frame: one year ] [ Designated as safety issue: No ]
- triglycerides [ Time Frame: one year ] [ Designated as safety issue: No ]
|Study Start Date:||February 2010|
|Study Completion Date:||June 2010|
|Primary Completion Date:||June 2010 (Final data collection date for primary outcome measure)|
Show 103 Study Locations
|Study Director:||Ales Kminek||AstraZeneca|
|Principal Investigator:||Jaromir Hradec||General faculty hospital Prague|
|Principal Investigator:||Jan Bultas||Faculty hospital Kralovske Vinohrady Prague|